Front-line treatment of advanced non-small cell lung cancer with docetaxel and Gemcitabine: A multicenter phase II trial

被引：0
|
作者：
Georgoulias, V [1 ]
Kourousis, C [1 ]
Kakolyris, S [1 ]
Dimopoulos, MA [1 ]
Papadakis, E [1 ]
Apostolopulou, F [1 ]
Agelidou, A [1 ]
Tzianni, V [1 ]
Sarra, E [1 ]
Vardakis, N [1 ]
机构：
[1] Univ Gen Hosp Heraklion, Dept Med Oncol, Greek Cooperat Grp Lung Canc, Heraklion 71110, Crete, Greece
来源：
ANNALS OF ONCOLOGY | 1998年 / 9卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
453
引用
收藏
页码：94 / 94
页数：1
相关论文
共 50 条
  • [1] Front-line treatment of advanced non-small-cell lung cancer with docetaxel and gemcitabine: A multicenter phase II trial
    Georgoulias, V
    Kouroussis, C
    Androulakis, N
    Kakolyris, S
    Dimopoulos, MA
    Papadakis, E
    Bouros, D
    Apostolopoulou, F
    Papadimitriou, C
    Agelidou, A
    Hatzakis, K
    Kalbakis, K
    Kotsakis, A
    Vardakis, N
    Vlachonicolis, J
    JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (03) : 914 - 920
  • [2] Front-line treatment of advanced non-small cell lung cancer with Docetaxel and Irinotecan: A multicenter phase II trial
    Ziotopoulos, P.
    Mylonaki, E.
    Boukovinas, J.
    Agelidou, M.
    Chandrinos, V.
    Zachariadis, E.
    Varthalitis, J.
    Ardavanis, A.
    Christopoulou, A.
    Georgoulias, V.
    ANNALS OF ONCOLOGY, 2004, 15 : 178 - 178
  • [3] Docetaxel versus docetaxel plus gemcitabine as front-line treatment of patients with advanced non-small cell lung cancer: A randomized, multicenter phase III trial
    Georgoulias, Vassilis
    Androulakis, Nikolaos
    Kotsakis, Athanasios
    Hatzidaki, Dora
    Syrigos, Kostas
    Polyzos, Aris
    Agelidou, Athina
    Varthalitis, Loannis
    Ziras, Nikoalos
    Agelidou, Maria
    Chandrinos, Vassilis
    Boukovinas, Loannis
    Geroyianni, Alexandra
    Vamakas, Larnbros
    Mavroudis, Dirnitris
    LUNG CANCER, 2008, 59 (01) : 57 - 63
  • [4] A multicenter phase II study of docetaxel and carboplatin combination as front-line treatment in advanced non-small cell lung cancer
    Giannakakis, T
    Kakolyris, S
    Theodoropoulos, E
    Kouroussis, C
    Michailakis, E
    Papadouris, S
    Tsitoura, M
    Kalbakis, K
    Souglakos, J
    Agelaki, S
    Vardakis, N
    Georgoulias, V
    ANTICANCER RESEARCH, 2002, 22 (6B) : 3743 - 3748
  • [5] Front-line treatment of advanced non-small cell lung cancer with irinotecan and docetaxel: A multicentre phase II study
    Ziotopoulos, P
    Androulakis, N
    Mylonaki, E
    Chandrinos, V
    Zachariadis, E
    Boukovinas, I
    Agelidou, A
    Kentepozidis, N
    Ignatiadis, M
    Vossos, A
    Georgoulias, V
    LUNG CANCER, 2005, 50 (01) : 115 - 122
  • [6] Administration of pemetrexed immediately following gemcitabine as front-line therapy in advanced non-small cell lung cancer: A phase II trial
    Treat, Joseph
    Bonomi, Philip
    McCleod, Michael
    Christiansen, Neal P.
    Mintzer, David M.
    Monberg, Matthew J.
    Ye, Zhishen
    Chen, Ruqin
    Obasaju, Coleman K.
    LUNG CANCER, 2006, 53 (01) : 77 - 83
  • [7] Docetaxel versus docetaxel plus cisplatin as front-line treatment of patients with advanced non-small-cell lung cancer: A randomized, multicenter phase III trial
    Georgoulias, V
    Ardavanis, A
    Agelidou, A
    Agelidou, M
    Chandrinos, V
    Tsaroucha, E
    Toumbis, M
    Kouroussis, C
    Syrigos, K
    Polyzos, A
    Samaras, N
    Papakotoulas, P
    Christofilakis, C
    Ziras, N
    Alegakis, A
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (13) : 2602 - 2609
  • [8] Randomised multicenter phase II study of two schedules of docetaxel and gemcitabine or cisplatin/gemcitabine followed by docetaxel as first line treatment for advanced non-small cell lung cancer
    Novello, Silvia
    Falcone, Alfredo
    Crino, Lucio
    Rinaldi, Massimo
    Nardi, Mario
    De Marinis, Filippo
    Tonato, Maurizio
    Tibaldi, Carmelo
    Tinazzi, Angelo
    Russo, Francesca
    Grassivaro, Nicoletta
    Scagliotti, Giorgio Vittorio
    LUNG CANCER, 2009, 66 (03) : 327 - 332
  • [9] Results of a phase II multicenter trial of weekly docetaxel and gemcitabine as first-line therapy for patients with advanced non-small cell lung cancer
    Neubauer, MA
    Garfield, DH
    Kuerfler, PR
    Raju, RN
    Lindquist, DL
    Soo, EW
    Khan, M
    Boehm, KA
    Asmar, L
    LUNG CANCER, 2005, 47 (01) : 121 - 127
  • [10] Phase II trial of docetaxel and carboplatin in the treatment of advanced non-small cell lung cancer
    Schutte, W
    Bork, I
    Wollschlager, B
    Schadlich, S
    EUROPEAN JOURNAL OF CANCER, 1997, 33 : 1076 - 1076
12345